SCHEMBL24944460

SCHEMBL24944460

CNc1nc(Nc2cccc(N3CCN(C)CC3)c2)c(C(N)=O)nc1-c1cncc2c1ncn2C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EML4 Q9HC35 5/20 0.51
▸ ALK Q9UM73 5/20 0.51
▸ CDK2 P24941 9/20 0.46
▸ AURKA O14965 2/20 0.46
▸ CCNA2 P20248 6/20 0.45
▸ CCNA1 P78396 2/20 0.45
▸ ROS1 P08922 4/20 0.42
▸ FLT3 P36888 4/20 0.42
▸ SYK P43405 2/20 0.42
▸ PLK4 O00444 1/20 0.42
▸ CHEK1 O14757 1/20 0.42
▸ PRKD3 O94806 1/20 0.42
▸ LCK P06239 1/20 0.42
▸ CSF1R P07333 1/20 0.42
▸ KIT P10721 1/20 0.42
▸ FGFR1 P11362 1/20 0.42
▸ SRC P12931 1/20 0.42
▸ FLT1 P17948 1/20 0.42
▸ FGFR3 P22607 1/20 0.42
▸ MARK3 P27448 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30205535 1.00 EML4 (0.51) EML4ALKCDK2AURKACCNA2
SCHEMBL29173496 0.92 EML4 (0.42) EML4ALKCDK2AURKACCNA2
SCHEMBL24944782 0.91 RET (0.49) EML4ALKCDK2AURKACCNA2
SCHEMBL24944461 0.86 EML4 (0.42) EML4ALKROS1FLT3SYK
SCHEMBL24943828 0.85 CDK2 (0.37) CDK2AURKACCNA2CCNA1SYK
SCHEMBL30205989 0.84 CDK2 (0.40) EML4ALKCDK2CCNA2CCNA1
SCHEMBL29173447 0.84 CDK2 (0.40) EML4ALKCDK2CCNA2CCNA1
Formic Acid SCHEMBL30205508 0.84 EML4 (0.40) EML4ALKROS1FLT3SYK
Formic Acid SCHEMBL29173289 0.84 EML4 (0.40) EML4ALKROS1FLT3SYK
SCHEMBL24944209 0.84 SYK (0.44) EML4ALKCDK2AURKACCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN claimed
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN disclosed
WO-2023001794-A1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2023-01-26 — — WO disclosed
Send feedback